首页|盐酸川芎嗪注射液联合倍他司汀片治疗眩晕的疗效分析

盐酸川芎嗪注射液联合倍他司汀片治疗眩晕的疗效分析

扫码查看
目的 分析盐酸川芎嗪注射液联合倍他司汀片治疗眩晕的疗效。方法 围绕洛阳市涧西区瀛洲街道社区卫生服务中心 2019 年 12 月至 2022 年 12 月 62 例眩晕症患者展开研究;依据随机数字表法进行分组(对照组、研究组各纳入 31 例),对照组药物治疗方案为单纯倍他司汀片,研究组药物治疗方案为盐酸川芎嗪注射液联合倍他司汀片。比较两组治疗有效率、治疗前后眩晕相关量表评分[眩晕残障程度评定量表(DHI)、眩晕残障问卷(VHQ)]变化情况、基础症状缓解时间、各动脉脑血流量变化情况、用药期间不良反应发生情况。结果 研究组治疗有效率(96。77%)与对照组(77。42%)相比较高,差异具有统计学意义(P<0。05);治疗前两组DHI、VHQ评分对比未差异无统计学意义(P>0。05),治疗后两组DHI、VHQ评分均与同组治疗前相比明显降低,且研究组降低幅度大于对照组,差异均有统计学意义(P<0。05);研究组眩晕、恶心、呕吐、行走困难症状缓解时间与对照组相比较短,差异具有统计学意义(P<0。05);治疗前两组各动脉脑血流量对比差异无统计学意义(P>0。05),治疗后两组右颈内动脉、左颈内动脉、右椎动脉、左椎动脉、基底动脉脑血流量均较同组治疗前明显升高,且研究组升高幅度大于对照组,差异具有统计学意义(P<0。05);对照组用药治疗期间不良反应发生率(9。68%)与研究组(12。90%)对比差异无统计学意义(P>0。05)。结论 盐酸川芎嗪注射液+倍他司汀片是治疗眩晕优质的联合用药方案,疗效确切且对各动脉脑血流量的具有明确改善作用,值得应用。
Analysis of the Effect of Hydrochloride Ligustrazine Injection combined with Betahistine Tablets in the Treatment of Vertigo
Objective To analyze the therapeutic effect of ligustrazine hydrochloride injection combined with betahistine tablets in the treatment of vertigo.Methods A study was conducted on 62 patients with vertigo from December 2019 to December 2022 at Yingzhou Street Community Health Service Center in Jianxi District,Luoyang City;According to the random number table method,grouping was carried out(31 cases were included in the control group and 31 cases in the study group).The drug treatment plan for the control group was simple betahistine tablets,while the drug treatment plan for the study group was a combination of ligustrazine hydrochloride injection and betahistine tablets.The effective rate of treatment between two groups,the changes in dizziness related scale scores before and after treatment[dizziness handicap inventory(DHI),vertigo handicap questionnaire(VHQ)],the time for relief of basic symptoms,changes in cerebral blood flow of each artery,and the occurrence of adverse reactions during medication were compared.Results The effective rate of treatment in the study group(96.77%)was higher than that in the control group(77.42%),and the difference was statistically significant(P<0.05);There was no statistically significant difference in DHI and VHQ scores between the two groups before treatment(P>0.05).After treatment,the DHI and VHQ scores in both groups decreased significantly compared to those in the same group before treatment,and the reduction in the study group was greater than that in the control group,with statistical differences(P<0.05);The relief time for symptoms of dizziness,nausea,vomiting,and difficulty walking in the study group was shorter than that in the control group,and the difference was statistically significant(P<0.05);There was no statistically significant difference in cerebral blood flow between the two groups before treatment(P>0.05).After treatment,the cerebral blood flow of the right internal carotid artery,left internal carotid artery,right vertebral artery,left vertebral artery,and basilar artery in both groups significantly increased compared to those before treatment in the same group,and the increase in the study group was greater than that in the control group,with a statistically significant difference(P<0.05);There was no statistically significant difference in the incidence of adverse reactions during medication treatment between the control group(9.68%)and the study group(12.90%)(P>0.05).Conclusion Ligustrazine hydrochloride injection combined with betahistine tablets is a high-quality combination therapy for the treatment of dizziness,with definite therapeutic effects and a clear improvement effect on cerebral blood flow in various arteries,which is worthy of application.

ligustrazine hydrochloride injectionbetahistine tabletsvertigoarterial cerebral blood flow

王会议、杨安民

展开 >

洛阳市涧西区瀛洲街道社区卫生服务中心 中医科,河南 洛阳 471003

洛阳市东方人民医院 中医科,河南 洛阳 471003

盐酸川芎嗪注射液 倍他司汀片 眩晕 动脉脑血流量

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(2)
  • 20